Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen
4 months ago
Deals
Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets
4 months ago
People
Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial
4 months ago
R&D
Eikon Therapeutics raises $351M Series D as lead drug starts Phase 3
4 months ago
Financing
Chicago biotech Emalex says it cleared a Phase 3 for Tourette syndrome, will seek FDA approval
4 months ago
R&D
En vogue Chinese ADC biotech lets Hong Kong IPO filing lapse
4 months ago
Financing
China
BridGene nets another Takeda deal amid plans to raise more funding and go public
4 months ago
Deals
Pharma
How Keymed steered the China-to-US NewCo model in biotech
4 months ago
Deals
China
Paris startup collects €27M in Series B to advance overactive bladder treatment
4 months ago
Financing
Startup that mines ‘junk DNA’ secures R&D deal with Merck
4 months ago
Deals
Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down
4 months ago
R&D
Exclusive: Lux leads $25M Series A in a Lithuanian startup plotting US expansion
4 months ago
Financing
Pain biotech Latigo eyes up to $150M raise following Vertex's landmark FDA nod
4 months ago
Financing
Kojin Therapeutics shuts down, citing lack of investor interest and complex science
4 months ago
People
Hunger-suppressing biotech Aardvark raises $94M in IPO
4 months ago
Financing
Newleos, a new biotech with $93.5M, repurposes Roche's experimental CNS drugs
4 months ago
Deals
Pharma
After passing on M&A offers, Abcuro raises $200M in bid to become commercial drugmaker
4 months ago
Financing
Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listing
5 months ago
Financing
Less than two years after blockbuster IPO, Acelyrin merges with Alumis to combine cash, assets
5 months ago
Deals
With first drug now in the clinic, Alys eyes megaround for rest of pipeline
5 months ago
Financing
How opioid addiction treatment startup Bicycle Health reached a profit
5 months ago
Health Tech
Flagship spinout Omega is days away from bankruptcy, filing shows
5 months ago
People
Sionna seeks $135M IPO to fuel tests of cystic fibrosis drug candidates
5 months ago
Financing
Australian biotech AdvanCell nabs $112M Series C for radiopharmaceuticals
5 months ago
Financing
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page